MicroMend
2011
FOUNDED
PRIVATE
STATUS
Later Stage VC
LATEST DEAL TYPE
$300K
LATEST DEAL AMOUNT
11
INVESTORS
Description
Developer of wounds closure device designed to provide a new alternative to sutures and staples for skin closure. The company's device has the added feature of tiny micro staples that allow it to achieve similar holding strength to sutures, and thus close wounds currently requiring sutures or staples, enabling medical practitioners to treat skin wounds like surgical incisions and lacerations.
Website
Formerly Known As
Marco Pharmaceuticals, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
- 500 Yale Avenue North
- Suite 100
- Seattle, WA 98109
- United States
+1 (206) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore MicroMend’s full profile, request a free trial.
MicroMend Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 24-Jun-2019 | $300K | 00.000 | Completed | Generating Revenue | |
| 6. Later Stage VC | 01-Nov-2018 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series A) | 01-Jun-2018 | 00.000 | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A1) | 02-Mar-2017 | 00000 | 00.000 | 00.00 | Completed | Generating Revenue |
| 3. Grant | 01-Jan-2015 | 00.000 | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 23-Dec-2014 | $2.25M | $2.25M | 00.000 | Completed | Startup |
| 1. Grant | 01-Dec-2012 | $1.75M | Completed | Startup |
MicroMend Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
MicroMend Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gecko Biomedical | Venture Capital-Backed | Paris, France | 00 | 0000 | 0000000000 | 0000 |
| 00000000 | Venture Capital-Backed | Caesarea, Israel | 00 | 0000 | 00000000000 | 0000 |
| 0000000 | Venture Capital-Backed | San Luis Obispo, CA | 00 | 000.00 | 000000000. 0 | 000.00 |
| 0000000 0000000 | Venture Capital-Backed | Campbell, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Leeds, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
MicroMend Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Elevate Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Thynk Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Wallace H. Coulter Foundation | Limited Partner | 000 0000 | 000000 0 | |||
| Cornerstone Angels | Angel Group | Minority | 000 0000 | 000000 0 |
MicroMend Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Ronald Berenson MD | Co-Founder, President, Chief Executive Officer and Board Member | ||
| Marco Rolandi Ph.D | Co-Founder |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »MicroMend Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Cameron Pollock | Self | Board Member | 000 0000 | |
| Henry Kim | Self | Board Member | 000 0000 | |
| Jens Quistgaard Ph.D | Self | Board Member | 000 0000 | |
| John Brzezenski | Self | Board Member | 000 0000 | |
| Michael Gruber | Cornerstone Angels | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 7 board members. Get the full list »